176 Successful generation of tumor-infiltrating lymphocyte (TIL) product from renal cell carcinoma (RCC) tumors for adoptive cell therapy

• David McDermott,
• Virginia Seery,
• Rupal Bhatt,
• Adrian Wells,
• Mamta Gupta,
• Brian Halbert,
• David Einstein,
• Emanuelle Andrianopoulos,
• Kenneth Onimus,
• Courtney Herman,
• Shwetha Lakshmipathi,
• Arvind Natarajan,
• Anand Veerapathran

Affiliations

David McDermott

2Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, MA, USA

Virginia Seery

Aff2 grid.239395.70000000090118547Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center 10 Highfield Circle 02186 Milton MA USA

Rupal Bhatt

Aff70 grid.239395.70000000090118547Beth Israel Deaconess Medical Center Boston MA USA

Adrian Wells

Faculty of Biology, Medicine and Health, School of Psychological Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, Manchester, UK

Mamta Gupta

Alchemist Research and Data Analysis, Chandigarh, India

Brian Halbert

1BIDMC, Boston, MA, USA

David Einstein

1BIDMC, Boston, MA, USA

Emanuelle Andrianopoulos

1BIDMC, Boston, MA, USA

Kenneth Onimus

2Iovance Biotherapeutics, San Carlos, CA, USA

Courtney Herman

2Iovance Biotherapeutics, San Carlos, CA, USA

Shwetha Lakshmipathi

2Iovance Biotherapeutics, San Carlos, CA, USA

Arvind Natarajan

2Iovance Biotherapeutics, San Carlos, CA, USA

Anand Veerapathran

2Iovance Biotherapeutics, San Carlos, CA, USA